These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7882004)

  • 1. Hypothalamic cholinergic and noradrenergic neurons in hyperglycemia induced by 2-deoxyglucose.
    Takahashi A; Ishimaru H; Ikarashi Y; Kishi E; Maruyama Y
    Brain Res; 1994 Nov; 665(1):13-7. PubMed ID: 7882004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypothalamic cholinergic activity and 2-deoxyglucose-induced hyperglycemia.
    Takahashi A; Ishimaru H; Ikarashi Y; Kishi E; Maruyama Y
    Brain Res Bull; 1997; 43(1):65-8. PubMed ID: 9205797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase of hypothalamic cholinergic activity in 2-deoxyglucose hyperglycemia.
    Takahashi A; Ishimaru H; Ikarashi Y; Kishi E; Maruyama Y
    Neurosci Lett; 1994 Dec; 182(2):235-8. PubMed ID: 7715817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypothalamic cholinergic activity associated with 2-deoxyglucose-induced hyperglycemia.
    Takahashi A; Ishimaru H; Ikarashi Y; Kishi E; Maruyama Y
    Brain Res; 1996 Sep; 734(1-2):116-22. PubMed ID: 8896817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central suppressive effect of octreotide on the hyperglycemic response to 2-deoxy-D-glucose injection or cold-swim stress in awake rats: possible mediation role of hypothalamic noradrenergic drive.
    Gotoh M; Iguchi A; Kakumu S; Hirooka Y; Smythe GA
    Brain Res; 2001 Mar; 895(1-2):146-52. PubMed ID: 11259771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraventricular injection of neostigmine increases dopaminergic and noradrenergic nerve activities: hyperglycemic effects and neurotransmitters in the hypothalamus.
    Takahashi A; Ishimaru H; Ikarashi Y; Maruyama Y
    Neurosci Lett; 1993 Jun; 156(1-2):54-6. PubMed ID: 7692365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decrease of norepinephrine and preservation of acetylcholine in the hypothalamus of VMH obese rats.
    Takahashi A; Ishimaru H; Ikarashi Y; Maruyama Y
    Brain Res Bull; 1995; 36(1):97-9. PubMed ID: 7882057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of rat hypothalamus by microdialysis with K+: increase of ACh release elevates plasma glucose.
    Takahashi A; Kishi E; Ishimaru H; Ikarashi Y; Maruyama Y
    Am J Physiol; 1998 Nov; 275(5):R1647-53. PubMed ID: 9791086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypothalamic cholinergic systems in mercuric chloride-induced hyperglycemia.
    Takahashi A; Ishimaru H; Ikarashi Y; Maruyama Y
    Brain Res Bull; 1994; 34(1):47-52. PubMed ID: 7910776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspects of hypothalamic neuronal systems in VMH lesion-induced obese rats.
    Takahashi A; Ishimaru H; Ikarashi Y; Maruyama Y
    J Auton Nerv Syst; 1994 Aug; 48(3):213-9. PubMed ID: 7963256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCK and other peptides modulate hypothalamic norepinephrine release in the rat: dependence on hunger or satiety.
    Myers RD; Swartzwelder HS; Peinado JM; Lee TF; Hepler JR; Denbow DM; Ferrer JM
    Brain Res Bull; 1986 Oct; 17(4):583-97. PubMed ID: 3536002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral ghrelin participates in the glucostatic signaling mediated by the ventromedial and lateral hypothalamus neurons.
    Solomon A; De Fanti BA; Martínez JA
    Peptides; 2006 Jul; 27(7):1607-15. PubMed ID: 16580091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyrotropin-releasing hormone-induced hyperglycemia: possible involvement of cholinergic receptors in the lateral hypothalamus.
    Shen DC; Lin MT; Shian LR
    Neuroendocrinology; 1985 Dec; 41(6):499-503. PubMed ID: 3935944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Swimming stress that causes hyperglycemia increases in vivo release of noradrenaline, but not acetylcholine, from the hypothalamus of conscious rats.
    Gotoh M; Tajima T; Suzuki Y; Ikari H; Iguchi A; Kakumu S; Hirooka Y
    Brain Res; 1998 Jan; 780(1):74-9. PubMed ID: 9473595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Octreotide-induced suppression of the hyperglycemic response to neostigmine or bombesin: relationship to hypothalamic noradrenergic drive.
    Gotoh M; Takagi J; Mori S; Yatoh M; Hirooka Y; Yamanouchi K; Smythe GA
    Brain Res; 2001 Nov; 919(1):155-9. PubMed ID: 11689173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-Methoxy-4-hydroxyphenylethyleneglycol concentrations in discrete hypothalamic nuclei reflect the activity of noradrenergic neurons.
    Lookingland KJ; Ireland LM; Gunnet JW; Manzanares J; Tian Y; Moore KE
    Brain Res; 1991 Sep; 559(1):82-8. PubMed ID: 1685939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium-dependent regulation of cholinergic cell phenotype in the hypothalamus in vitro.
    Belousov AB; Hunt ND; Raju RP; Denisova JV
    J Neurophysiol; 2002 Sep; 88(3):1352-62. PubMed ID: 12205156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opposite effects of noradrenaline and acetylcholine upon hypocretin/orexin versus melanin concentrating hormone neurons in rat hypothalamic slices.
    Bayer L; Eggermann E; Serafin M; Grivel J; Machard D; Muhlethaler M; Jones BE
    Neuroscience; 2005; 130(4):807-11. PubMed ID: 15652980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of acetylcholine on corticotropin-releasing factor gene expression in the hypothalamic paraventricular nucleus of conscious rats.
    Ohmori N; Itoi K; Tozawa F; Sakai Y; Sakai K; Horiba N; Demura H; Suda T
    Endocrinology; 1995 Nov; 136(11):4858-63. PubMed ID: 7588217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of central noradrenergic neuronal activity inhibits hyperglycemia.
    Smythe GA; Edwards SR
    Am J Physiol; 1992 Nov; 263(5 Pt 1):E823-7. PubMed ID: 1443113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.